PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
January 1, 1989Biological Chemistry Hoppe-Seyler341 citations

Low Concentrations of Acid-Soluble Thiol (Cysteine) in the Blood Plasma of HIV-1-Infected Patients

View Full Paper
HEHans‐Peter EckGerman Cancer Research CenterHGHelmut GmünderGerman Cancer Research CenterMHMartin HartmannFriedrich-Alexander-Universität Erlangen-Nürnberg

Key Points

  • To investigate the concentrations of cysteine and glutamate in the blood plasma of HIV-1-infected persons and their potential implications.
  • Analyzed blood plasma samples from HIV-1-infected individuals to measure thiol and glutamate levels.
  • Conducted cell culture experiments with varying extracellular cysteine concentrations.
  • Assessed intracellular glutathione levels and rate of DNA synthesis in T cell clones and lymphocyte preparations.
  • Plasma cysteine concentrations were significantly decreased in HIV-1-infected individuals.
  • Plasma glutamate levels were elevated up to 6-fold the normal level.
  • AZT therapy increased plasma thiol levels but did not normalize intracellular glutathione or plasma glutamate levels.

Abstract

Blood plasma samples from HIV-1-infected persons contain elevated glutamate concentrations up to 6-fold the normal level and relatively low concentrations of acid-soluble thiol (i.e. decreased cysteine concentrations). The intracellular glutathione concentration in peripheral blood-mononuclear cells (PBMC) and monocytes from HIV antibody-positive persons are also significantly decreased. Therapy with azidothymidine (AZT) causes a substantial recovery of the plasma thiol levels; but glutamate levels remain significantly elevated and intracellular glutathione levels remain low. Cell culture experiments with approximately physiological amino-acid concentrations revealed that variations of the extracellular cysteine concentration have a strong influence on the intracellular glutathione level and the rate of DNA synthesis ( 3Hthymidine incorporation) in T cell clones and human and murine lymphocyte preparations even in the presence of several-fold higher cystine and methionine concentrations. Cysteine cannot be replaced by a corresponding increase of the extracellular cystine or methionine concentration. These experiments suggest strongly that the low cysteine concentration in the plasma of HIV-infected persons may play a role in the pathogenetic mechanism of the acquired immunodeficiency syndrome.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Eck et al. (1989) studied this question.

synapsesocial.com/papers/6a0cbac4cf313b58ec7a6723https://doi.org/10.1515/bchm3.1989.370.1.101
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Efficacy and Safety of Glutathione Supplementation in Patients with HIV Infection and HIV-Tuberculosis Co-Infection2026 · 2 citations
  2. 2Vagal System Impairment in Human Immunodeficiency Virus-Positive Patients with Chronic Hepatitis C: Does Hepatic Glutathione Deficiency Have a Pathogenetic Role?1997 · 22 citations
  3. 3Effects of HIV and azidothymidine on Alzheimer’s-like pathology and amyloid beta transporters in hu-PBL-NSG mice, brain endothelial amyloid beta uptake and endothelial barrier integrity2026
  4. 4Reversal of perturbed DNA damage response and HIV latency by a histone methyltransferase inhibitor in virally suppressed individuals living with HIV2025
  5. 5Phylogenetic position and genetic features of HIV-1 in CNS2024